Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
22.12
+0.31 (1.42%)
At close: Oct 23, 2026

SHA:603207 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
553.96525.28474.58471.87456.89401.77
Revenue Growth
9.78%10.68%0.57%3.28%13.72%11.22%
Gross Profit
332.25341.25311.3308.8269.45254.43
Operating Income
217.86238.19233.49230.48195.85142.84
Net Income
193.15207.49205.27203.63175.18126.27
Earnings Per Share
1.191.291.531.701.461.05
EPS Growth
-10.30%-15.69%-10.00%16.44%39.05%-

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
East China
182.77
North China
69.59
South China
85.52
Southwest
59.12
Central China
58.87
Northeast
45.23
Northwest
23.4
Overseas
0.21
Total
524.7

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
721.47647.59883.43288.52168.93208.01
Total Debt
5.552.52.320.860.881.27
Net Cash (Debt)
715.92645.08881.11287.65168.05206.74
Net Cash Growth
-2.34%-26.79%206.31%71.17%-18.71%83.45%
Net Cash Per Share
4.414.016.572.401.401.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
198.87160.8212.21200.26137.2179.51
Capital Expenditures
-71.69-54.24-83.94-80.15-61.59-12.48
Free Cash Flow
127.17106.56128.27120.1175.61167.03
Free Cash Flow Growth
12.64%-16.93%6.79%58.86%-54.73%20.59%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
59.98%64.96%65.59%65.44%58.97%63.33%
Operating Margin
39.33%45.35%49.20%48.84%42.86%35.55%
Pretax Margin
40.31%45.92%50.47%50.26%45.10%38.47%
Profit Margin
34.87%39.50%43.25%43.15%38.34%31.43%
FCF Margin
22.96%20.29%27.03%25.45%16.55%41.57%

Dividends

Fiscal Year
CurrentFY 2025FY 2024
Period EndingOct '26 Dec '25 Dec '24
Dividend Per Share
1.0701.0701.500
Dividend Per Share Growth
-65.45%-28.67%-
Dividend Yield
4.84%3.74%5.34%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
18.5722.1521.90---
P/FCF Ratio
27.9543.1335.04---
PS Ratio
6.428.759.47---